Skip to content

Therapeutic Efficacy and Safety of Ultrasound-Guided Lauromacrogol Sclerotherapy for Bilateral Ovarian Endometriotic Cysts

Therapeutic Efficacy and Safety of Ultrasound-Guided Lauromacrogol Sclerotherapy for Bilateral Ovarian Endometriotic Cysts: A Single-Center, Single-Arm, Prospective Study

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2400081345
Enrollment
Unknown
Registered
2024-02-28
Start date
2024-03-01
Completion date
Unknown
Last updated
2024-03-04

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

endometriotic cysts

Interventions

Single Group:ultrasound-guided lauromacrogol sclerotherapy

Sponsors

The Third Affiliated Hospital of Sun Yat-sen University
Lead Sponsor

Eligibility

Sex/Gender
Female
Age
No minimum to 55 Years

Inclusion criteria

Inclusion criteria: (1) Women aged 18 years or older with fertility requirements (2) Diagnosed by magnetic resonance imaging (MRI) or transvaginal (rectal) ultrasound as bilateral ovarian endometriotic cysts (3) Cyst diameter = 4cm (4) Willing to participate in the study and sign the informed consent form

Exclusion criteria

Exclusion criteria: (1) Patients who are pregnant, lactating, or in menstrual period; (2) Patients with poor general condition, psychological or mental illness who cannot tolerate or cooperate with treatment; (3) Patients with severe bleeding tendency, taking anticoagulants, or having coagulation disorders; (4) Uncontrolled acute pelvic inflammation; (5) Cannot rule out cysts with malignant tumor lesions, or CA125 = 200U/ml, or HE4 abnormally elevated; (6) There is no safe puncture path, and even with auxiliary measures, it is still impossible to avoid important organs such as major blood vessels or intestinal tract.

Design outcomes

Primary

MeasureTime frame
recurrence rate;

Secondary

MeasureTime frame
Visual Analog Scale;anti-Müllerian hormone;antral follicle count;Technical success rate;volume reduction rate;pregnancy rate;

Countries

China

Contacts

Public ContactMan Zhang

The Third Affiliated Hospital of Sun Yat-sen University

zhangman@zsdxfsdsyy.wecom.work+86 135 8056 9664

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026